| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c32775641a2462e0c791af0b9b077e08 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-171538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-969
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-806 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
1997-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396bea50cd689b1af89b67e7394d088f |
| publicationDate |
1998-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5852199-A |
| titleOfInvention |
Method for making carbamazephine derivative |
| abstract |
The present invention provides a novel carbamazepine hydrazide compound suitable for covalent attachment to a polymer particle reagent, having the general formula <IMAGE> The present invention provides a novel carbamazepine acid compound suitable for attachment to proteins for the production of carbamazepine immunogens. The carbamazepine antigen of the present invention has the following general structure: <IMAGE> where X is C=O, CH2 or SO2; Y is C=O, CH2, SO2; R is an alkyl and P is a protein or a hapten. |
| priorityDate |
1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |